STOCK TITAN

Rocket Lab president sells 15K shares in plan

Rocket Lab Corp (RKLB) reported that Marvin Bradford Clevenger, President of Rocket Lab USA, Inc., sold 15,051 shares of common stock on 2026-08-24 in three open-market transactions at weighted-average prices of $69.5345, $70.2023, and $71.1700 per share.

(Very High)
(Negative)
Form Type
4

Rhea-AI Filing Summary

Rocket Lab Corp (RKLB) reported that Marvin Bradford Clevenger, President of Rocket Lab USA, Inc., sold 15,051 shares of common stock on 2026-08-24 in three open-market transactions at weighted-average prices of $69.5345, $70.2023, and $71.1700 per share. According to the disclosure, these were sell-to-cover sales to satisfy tax withholding obligations arising from the vesting and settlement of previously granted restricted stock units, and were effected pursuant to a Rule 10b5-1 trading plan.

Positive

  • None.

Negative

  • None.

Insights

Analyzing...

Insider Clevenger Marvin Bradford
Role President, Rocket Lab USA, Inc
Sold 15,051 shs ($1.05M)
Type Security Shares Price Value
Sale Common Stock F1, F2 13,924 $69.5345 $968K
Sale Common Stock F1, F3 450 $70.2023 $32K
Sale Common Stock F1 677 $71.17 $48K
Holdings After Transaction: Common Stock — 458,924 shares (Direct)
Footnotes (3)
  1. F1. Represents the sale of shares pursuant to a "sell-to-cover" transaction in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person.
  2. F2. The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $69.0000 to $69.9900. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. F3. The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $70.0000 to $70.6400. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Shares sold (largest block) 13,924 shares of Common Stock Sale on 2026-08-24 at weighted-average price of $69.5345 per share
Additional shares sold 450 shares of Common Stock Sale on 2026-08-24 at weighted-average price of $70.2023 per share
Additional shares sold 677 shares of Common Stock Sale on 2026-08-24 at price of $71.1700 per share
Total shares sold 15,051 shares of Common Stock Net sell transactions on 2026-08-24 reported in the Form 4
Price range for one sale block $69.0000–$69.9900 per share Weighted-average $69.5345 sale; trades executed within this range
Price range for another sale block $70.0000–$70.6400 per share Weighted-average $70.2023 sale; trades executed within this range
sell-to-cover financial
"Represents the sale of shares pursuant to a "sell-to-cover" transaction"
Sell-to-cover is when part of newly issued or exercised company stock is immediately sold to pay required taxes and fees, so the recipient keeps the remaining shares. For investors this matters because it reduces the number of shares insiders or employees actually hold after a grant, can create small, routine share sales that aren’t signal of cashing out, and slightly increases share supply on the market—like selling a portion of a paycheck to cover the tax bill.
weighted-average price financial
"The price reported in Column 4 is a weighted-average price."
Weighted-average price is the average of multiple prices where each price is counted according to its size or importance—larger trades carry more weight than smaller ones, like averaging course grades by credit hours. It matters to investors because it gives a more realistic picture of the true price paid or received, helping assess trade execution, compare performance, calculate cost basis, and value positions more accurately than a simple average.
restricted stock units financial
"in connection with the vesting and settlement of restricted stock units"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Rule 10b5-1 trading plan regulatory
"transactions affirmed under a Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

FAQ

What insider transactions did RKLB disclose for Marvin Bradford Clevenger on this Form 4?

The filing reports that Marvin Bradford Clevenger sold 15,051 shares of Rocket Lab Corp common stock on 2026-08-24 in three open-market transactions, all reported as sales of non-derivative common stock held directly.

What were the sale prices for the RKLB shares sold by Marvin Bradford Clevenger?

The reported weighted-average sale prices were $69.5345, $70.2023, and $71.1700 per share. Footnotes explain that the actual trades occurred in price ranges of $69.0000–$69.9900 and $70.0000–$70.6400, with full breakdowns available upon request.

Why did Marvin Bradford Clevenger sell RKLB shares in this Form 4?

A footnote states the 15,051 shares were sold in a sell-to-cover transaction to satisfy applicable tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the reporting person.

Were the RKLB insider sales made under a Rule 10b5-1 trading plan?

Yes. The Form 4 indicates the transactions were effected pursuant to a Rule 10b5-1 trading plan, meaning the trades were made under a pre-established plan rather than discretionary same-day trading.

How many RKLB shares in total were sold in this Form 4 transaction set?

The transaction summary shows total net sales of 15,051 shares of Rocket Lab Corp common stock on 2026-08-24, consisting of blocks of 13,924, 450, and 677 shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Clevenger Marvin Bradford

(Last)(First)(Middle)
3881 MCGOWEN STREET

(Street)
LONG BEACH CALIFORNIA 90808

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Rocket Lab Corp [ RKLB ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
President, Rocket Lab USA, Inc
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/24/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock08/24/2026S13,924(1)D$69.5345(2)460,051D
Common Stock08/24/2026S450(1)D$70.2023(3)459,601D
Common Stock08/24/2026S677(1)D$71.17458,924D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Represents the sale of shares pursuant to a "sell-to-cover" transaction in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person.
2. The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $69.0000 to $69.9900. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
3. The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $70.0000 to $70.6400. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
By: /s/ Arjun Kampani, as Attorney-in-Fact For: Marvin B. Clevenger08/26/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)